DE60014400D1 - Antiadhäsionsschicht aus hyaluronsäure - Google Patents

Antiadhäsionsschicht aus hyaluronsäure

Info

Publication number
DE60014400D1
DE60014400D1 DE60014400T DE60014400T DE60014400D1 DE 60014400 D1 DE60014400 D1 DE 60014400D1 DE 60014400 T DE60014400 T DE 60014400T DE 60014400 T DE60014400 T DE 60014400T DE 60014400 D1 DE60014400 D1 DE 60014400D1
Authority
DE
Germany
Prior art keywords
hyaluronic acid
crosslinked hyaluronic
methods
adhesion layer
foam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60014400T
Other languages
English (en)
Other versions
DE60014400T2 (de
Inventor
Gary Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Surgical Corp
Original Assignee
United States Surgical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Surgical Corp filed Critical United States Surgical Corp
Publication of DE60014400D1 publication Critical patent/DE60014400D1/de
Application granted granted Critical
Publication of DE60014400T2 publication Critical patent/DE60014400T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00217—Wound bandages not adhering to the wound
DE60014400T 1999-07-28 2000-07-26 Antiadhäsionsschicht aus hyaluronsäure Expired - Lifetime DE60014400T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14606599P 1999-07-28 1999-07-28
US146065P 1999-07-28
PCT/US2000/040491 WO2001006973A1 (en) 1999-07-28 2000-07-26 Hyaluronic acid anti-adhesion barrier

Publications (2)

Publication Number Publication Date
DE60014400D1 true DE60014400D1 (de) 2004-11-04
DE60014400T2 DE60014400T2 (de) 2005-10-06

Family

ID=22515723

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60014400T Expired - Lifetime DE60014400T2 (de) 1999-07-28 2000-07-26 Antiadhäsionsschicht aus hyaluronsäure

Country Status (8)

Country Link
US (2) US6630167B2 (de)
EP (1) EP1207828B1 (de)
AT (1) ATE277647T1 (de)
AU (1) AU780363B2 (de)
CA (1) CA2377544C (de)
DE (1) DE60014400T2 (de)
ES (1) ES2223583T3 (de)
WO (1) WO2001006973A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2377544C (en) * 1999-07-28 2008-09-23 United States Surgical Corporation Hyaluronic acid anti-adhesion barrier
WO2002064182A2 (en) * 2001-02-14 2002-08-22 Genzyme Corporation Biocompatible fleece for hemostasis and tissue engineering
EP1465547A4 (de) * 2001-12-28 2008-04-30 Genzyme Corp Biologisch absorbierbare schaumstoffverpackungsvorrichtung und ihre verwendung
FR2840801B1 (fr) 2002-06-18 2005-06-03 Cie De Rech En Composants Impl Implant prothetique composite
US20040220534A1 (en) * 2003-04-29 2004-11-04 Martens Paul W. Medical device with antimicrobial layer
US20070020314A1 (en) * 2003-06-30 2007-01-25 Hirotaka Haro Adhesion inhibiting material for vertebral/spinal operation
US7332179B2 (en) 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
US7758654B2 (en) * 2004-05-20 2010-07-20 Kensey Nash Corporation Anti-adhesion device
WO2006036984A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Stand-alone film and methods for making the same
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) * 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
FR2865379B1 (fr) * 2005-03-02 2008-11-14 Cie De Rech En Composants Impl Implant prothetique composite
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US20060251702A1 (en) * 2005-05-05 2006-11-09 Cook Biotech Incorporated Implantable materials and methods for inhibiting tissue adhesion formation
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2007103208A2 (en) * 2006-03-01 2007-09-13 Fmc Biopolymer As Biodegradable foam
US20080069855A1 (en) * 2006-08-21 2008-03-20 Bonutti Peter M Method of inhibiting the formation of adhesions and scar tissue and reducing blood loss
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057344A2 (en) * 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
WO2009108760A2 (en) 2008-02-26 2009-09-03 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
WO2010040131A2 (en) * 2008-10-03 2010-04-08 Replication Medical, Inc. Vessel protection device
US20100159046A1 (en) * 2008-12-19 2010-06-24 Xylos Corporation Minimal tissue attachment implantable materials
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
US9095558B2 (en) 2010-10-08 2015-08-04 Board Of Regents, The University Of Texas System Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
ITMI20120732A1 (it) 2012-05-03 2013-11-04 B S Srl Polisaccaridi reticolati a memoria di forma
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
KR101598329B1 (ko) 2013-03-20 2016-02-29 일동제약주식회사 히알루론산의 제조방법 및 상기 제조방법으로 제조된 히알루론산을 포함하는 유착방지용 조성물
EP3165233B1 (de) * 2015-08-28 2021-08-18 Latvijas Universitate Biomaterial zur behandlung von akuten und chronischen hautwunden
ITUA20164153A1 (it) 2016-06-07 2017-12-07 Jointherapeutics S R L Composizioni polisaccaridiche impiegabili nella riparazione tissutale
CN109789249B (zh) 2016-06-15 2022-01-25 土耳其科学技术研究理事会 多功能疝气贴片
WO2018164358A1 (ko) 2017-03-07 2018-09-13 (주)진우바이오 히알루론산염 필름의 제조방법 및 이로부터 제조된 히알루론산염 필름
US11530302B2 (en) * 2017-12-29 2022-12-20 Matex Lab S.P.A. Method to prepare a filler with a hyaluronic acid base using specific crosslinking agents
CN108853569B (zh) * 2018-06-27 2021-06-11 湖南玉津医疗科技有限公司 一种共价交联透明质酸气凝胶及其水凝胶以及制备方法
CA3142730A1 (en) * 2019-06-04 2020-12-10 Aquavit Pharmaceuticals, Inc. Methods and compositions for microflillng the skin with hyaluronic acid using microchannel technology
US11202753B1 (en) 2020-03-06 2021-12-21 Aquavit Pharmaceuticals, Inc. Systems and methods for generating immune responses in subjects using microchannel delivery devices

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757195A (fr) 1969-10-07 1971-03-16 Century Disposable Devices Seringue servant a injecter un melange fraichement prepare de poudre etde liquide
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4517295A (en) 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE456346B (sv) * 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
US4636524A (en) 1984-12-06 1987-01-13 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4582865A (en) 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5356883A (en) * 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
GR920100122A (el) 1991-04-05 1993-03-16 Ethicon Inc Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως.
US5840777A (en) * 1992-06-19 1998-11-24 Albany International Corp. Method of producing polysaccharide foams
SE9400036D0 (sv) * 1994-01-10 1994-01-10 Pharmacia Ab Low modecular weight hyaluronic acid
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
CA2377544C (en) * 1999-07-28 2008-09-23 United States Surgical Corporation Hyaluronic acid anti-adhesion barrier
US6957397B1 (en) * 2001-06-11 2005-10-18 Palm, Inc. Navigating through a menu of a handheld computer using a keyboard

Also Published As

Publication number Publication date
US20040013714A1 (en) 2004-01-22
WO2001006973A1 (en) 2001-02-01
EP1207828A1 (de) 2002-05-29
CA2377544A1 (en) 2001-02-01
US20020141968A1 (en) 2002-10-03
EP1207828A4 (de) 2003-01-08
ES2223583T3 (es) 2005-03-01
US6630167B2 (en) 2003-10-07
AU780363B2 (en) 2005-03-17
ATE277647T1 (de) 2004-10-15
EP1207828B1 (de) 2004-09-29
DE60014400T2 (de) 2005-10-06
AU7626700A (en) 2001-02-13
CA2377544C (en) 2008-09-23

Similar Documents

Publication Publication Date Title
DE60014400D1 (de) Antiadhäsionsschicht aus hyaluronsäure
FI965068A (fi) Polymeerimikropartikkelit lääkkeen antamista varten
ATE211906T1 (de) Zusammensetzung und dosisform mit einem opioid- antagonisten
FI970810A0 (fi) Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja
ATE289332T1 (de) Silikongel enthaltend salizylsäure
DE19981583T1 (de) Verfahren zur Herstellung von Ethylen und Propylen
DE60035029D1 (de) Verfahren zur herstellung von furfural
WO2000073418A3 (en) A method of using autologous fibroblasts to promote healing of wounds and fistulas
FI965203A (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
MXPA04003597A (es) Conjugados polimericos de antagonistas opiaceos.
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
ATE287705T1 (de) Wärmegellierende bioabbaubare wässrige polymerlösung
WO2007053574A3 (en) Combinations comprising sorafenib and interferon for the treatment of cancer
DE60029464D1 (de) Verfahren zur herstellung von äthylen polymere
DE60023831D1 (de) Verfahren zur herstellung von polyhydroxycarboxylsäure
DE69939470D1 (de) Verfahren zur herstellung von cyclosporin-derivaten
DE60117232D1 (de) Verfahren zur simultanen oder nicht simultanen Herstellung von monolalkylaromatischen, dialkylaromatischen und trialkylaromatischen Verbindungen
DE60115971D1 (de) Verfahren zur Herstellung von Cellulosepolymeren
PL376506A1 (en) Lactide and glycolide (co)polymerization catalytic system
ATE236191T1 (de) Substituierte phenyl-alkenoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikamente oder diagnostika sowie sie enthaltende medikamente
DE60024595D1 (de) Verfahren zur herstellung von äthylen polymere
DE60105890D1 (de) Verfahren zur Hemmung der Polymerisierung von ungesättigten Monomeren sowie deren Herstellung
ATE320461T1 (de) Verfahren zur herstellung und verwendung von geträgerten phosphazenium katalysatoren
WO2001068066A3 (en) A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
ATE264829T1 (de) Verfahren zur herstellung von acylierten 1,3- dicarbonylverbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition